VANCOUVER, BC, Sept. 18, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies today announced a focus on positive cash flow generating businesses, with several actions taken to reduce its cash expenses. These actions include ceasing…


Previous articleCOMPASS Pathways appoints Daphne Karydas to its Board of Directors
Next articleNuminus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine